A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Clinical trial NCT00808028 · COMPLETED

Trial details

NCT number: NCT00808028
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis, Meningococcal

Start date: 2009-02-01
Primary completion: 2014-03-01
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.